Notable Analyst Rating Changes 12/23: (ARIA) (LPSN) (FIVE) Upgraded; (MU) (BBRY) (NMM) Downgraded
Tweet Send to a Friend
UPGRADES
Chardan Capital Markets raises ARIAD Pharmaceuticals (Nasdaq: ARIA) from Neutral to Buy with a price target of $9 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Chardan Capital Markets raises ARIAD Pharmaceuticals (Nasdaq: ARIA) from Neutral to Buy with a price target of $9 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
